Cancer BiologyOncogenePeer-reviewed
Glutaminase as a metabolic target of choice to counter acquired resistance to Palbociclib by colorectal cancer cells
Míriam Tarrado‐Castellarnau, Carles Foguet, Josep Tarragó‐Celada…·Marta Cascante
This study shows that combining Palbociclib with Telaglenestat prevents acquired resistance in colorectal cancer cells by counteracting metabolic reprogramming.
12 citations